Clinical Trial Update: Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a mid-position strategy in radiotherapy for locally advanced, non-metastatic non-small cell lung cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Centre Leon Berard | Conditions: Non-small Cell Lung Cancer, Radiation Therapy | Phase 2 | Status: COMPLETED